Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.

MLA

Swanson B, et al. “Policosanol for Managing Human Immunodeficiency Virus-Related Dyslipidemia in a Medically Underserved Population: A Randomized, Controlled Clinical Trial.” Alternative Therapies in Health & Medicine, vol. 17, no. 2, Mar. 2011, pp. 30–35. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=108235725&authtype=sso&custid=ns315887.

APA

Swanson B, Keithley JK, Sha BE, Fogg L, Nerad J, Novak RM, Adeyemi O, Spear GT, Swanson, B., Keithley, J. K., Sha, B. E., Fogg, L., Nerad, J., Novak, R. M., Adeyemi, O., & Spear, G. T. (2011). Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Alternative Therapies in Health & Medicine, 17(2), 30–35.

Chicago

Swanson B, Keithley JK, Sha BE, Fogg L, Nerad J, Novak RM, Adeyemi O, et al. 2011. “Policosanol for Managing Human Immunodeficiency Virus-Related Dyslipidemia in a Medically Underserved Population: A Randomized, Controlled Clinical Trial.” Alternative Therapies in Health & Medicine 17 (2): 30–35. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=108235725&authtype=sso&custid=ns315887.